Skip to content
Brompheniramine
Bromanate, Bromfed-dm, Dimetane, Dimetane-dx, Dimetane-ten (brompheniramine) is a small molecule pharmaceutical. Brompheniramine was first approved as Dimetane-ten on 1982-01-01. It is used to treat allergic rhinitis perennial, common cold, urticaria, and vasomotor rhinitis in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
skin and connective tissue diseasesD017437
immune system diseasesD007154
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Brompheniramine maleate
Tradename
Company
Number
Date
Products
DIMETANE-TENWyethN-011418 DISCN1982-01-01
1 products
DIMETANEWyethN-010799 DISCN1982-01-01
3 products
Hide discontinued
Brompheniramine maleate
+
Dextromethorphan hydrobromide
+
Pseudoephedrine hydrochloride
Tradename
Company
Number
Date
Products
DIMETANE-DXA.H. Robins CompanyN-019279 DISCN1984-08-24
1 products, RLD
Hide discontinued
Brompheniramine maleate
+
Pseudoephedrine hydrochloride
Tradename
Company
Number
Date
Products
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATEAlzaN-019672 DISCN1996-03-29
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
dimetapp OTC monograph final2023-06-07
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
allergic rhinitis perennialEFO_1001417D012221J30.89
common coldEFO_0007214D003139J00
urticariaEFO_0005531D014581L50
vasomotor rhinitisEFO_0007533D012223J30.0
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
R: Respiratory system drugs
— R06: Antihistamines for systemic use
— R06A: Antihistamines for systemic use
— R06AB: Substituted alkylamines, systemic antihistamines
— R06AB01: Brompheniramine
— R06AB51: Brompheniramine, combinations
HCPCS
Code
Description
J0945
Injection, brompheniramine maleate, per 10 mg
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameBROMPHENIRAMINE
INNbrompheniramine
Description
Brompheniramine is pheniramine in which the hydrogen at position 4 of the phenyl substituent is substituted by bromine. A histamine H1 receptor antagonist, brompheniramine is used (commonly as its maleate salt) for the symptomatic relief of allergic conditions, including rhinitis and conjunctivitis. It has a role as a H1-receptor antagonist and an anti-allergic agent. It is a member of pyridines and an organobromine compound.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CN(C)CCC(c1ccc(Br)cc1)c1ccccn1
Identifiers
PDB—
CAS-ID86-22-6
RxCUI1767
ChEMBL IDCHEMBL811
ChEBI ID3183
PubChem CID6834
DrugBankDB00835
UNII IDH57G17P2FN (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 407 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
2 adverse events reported
View more details